>Mercado de purificação de vetores virais Ásia-Pacífico, por produto e serviços (produtos e serviços), tipo (vetores retrovirais, vírus vacinais, vetores adenovirais, vetores virais adeno-associados, lentivírus e outros), fluxo de trabalho (processamento upstream e processamento a jusante), purificação Técnica (Ultracentrifugação por Gradiente de Densidade, Ultrafiltração, Precipitação, Sistemas de Extração Bifásica e Cromatografia), Escala de Operação (Pré-clínica / Clínica e Comercial), Método de Entrega (In Vivo e Ex Vivo), Indicação de Doença (Cancro, Doenças Genéticas, Doenças Infecciosas , Doenças Veterinárias e Outras), Aplicação (Antisense e RNAi, Terapia Génica, Terapia Celular e Vacinologia), Utilizador Final (Empresas de Biotecnologia, Empresas Farmacêuticas, Organizações de Investigação Contratadas, Organização de Desenvolvimento e Fabricação por Contrato (CDMO) e Institutos Académicos/de Investigação) , País (Japão, China, Austrália, Índia, Coreia do Sul, Singapura, Indonésia, Tailândia, Malásia, Filipinas, Resto da Ásia-Pacífico) Tendências e previsões da indústria para 2028
Análise de mercado e insights: Mercado de purificação de vetores virais da Ásia-Pacífico
Espera-se que o mercado de purificação de vetores virais ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 15,3% no período de previsão de 2021 a 2028 e deverá atingir os 266,22 milhões de USD até 2028. A crescente procura de vetores virais está a atuar como um impulsionador para o mercado de purificação de vetores virais
Os biólogos moleculares utilizam frequentemente vetores virais para entregar material genético às células. Este procedimento pode ser realizado in vivo (dentro de um organismo vivo) ou em cultura celular (in vitro). Os vírus desenvolveram mecanismos moleculares especializados para transportar os seus genomas de forma eficiente dentro das células que infetam. A transdução é a entrega de genes ou outro material genético por um vetor e as células infetadas são referidas como transduzidas.
O surgimento do COVID-19 e a procura por vacinas virais estão a impulsionar o mercado de purificação de vetores virais. A falta de escalabilidade é uma restrição para o mercado de purificação de vetores virais. O aumento do número de doenças infeciosas atua como uma oportunidade para o mercado de purificação de vetores virais. A escassez de pessoal qualificado é um desafio para o mercado de purificação de vetores virais.
O relatório de mercado de purificação de vetores virais fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos. Para compreender a análise e o cenário do mercado de purificação de vetores virais, contacte a Data Bridge Market Research para obter um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.
Viral Vector Purification Market Scope and Market Size
The viral vector purification market is categorized into nine notable segments which are based on the product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product & services, the viral vector purification market is segmented into products and services. In 2021, products segment is expected to dominate the viral vector purification market due to availability of diverse range of innovative solutions for vector purification.
- On the basis of type, the viral vector purification market is segmented into retroviral vectors, vaccine virus, adenoviral vectors, adeno-associated viral vectors, lentivirus and other. In 2021, adeno-associated viral vectors segment is expected to dominate the viral vector purification market due to broad range of infectivity of AAV.
- On the basis of workflow, the viral vector purification market is segmented into upstream processing and downstream processing. In 2021, upstream processing segment is expected to dominate the viral vector purification market because the viral vectors produced using this process can be harvested from cells in a short window of time post transfection.
- On the basis of purification technique, the viral vector purification market is segmented into density-gradient ultracentrifugation, ultrafiltration, precipitation, two-phase extraction systems and chromatography. In 2021, chromatography segment is expected to dominate the viral vector purification market because it has been widely used for purification of vaccines and gene therapy vectors.
- On the basis of scale of operation, the viral vector purification market is segmented into preclinical / clinical and commercial. In 2021, preclinical / clinical segment is expected to dominate the viral vector purification market due to rising investment for research and development activities by major healthcare organizations.
- On the basis of delivery method, the viral vector purification market is segmented into in vivo and ex vivo. In 2021, in vivo segment is expected to dominate the viral vector purification market due to its high availability and process reliability.
- On the basis of disease indication, the viral vector purification market is segmented into cancer, genetic disorders, infectious diseases, veterinary disease and other. In 2021, genetic disorders segment is expected to dominate the viral vector purification market owing to the rising incidence and prevalence of genetic disorders.
- Com base na aplicação, o mercado de purificação de vetores virais está segmentado em antisense & RNAi, terapia genética, terapia celular e vacinologia. Em 2021, prevê-se que o segmento da terapia genética domine o mercado da purificação de vetores virais devido à vasta gama de aplicações no setor médico.
- Com base no utilizador final, o mercado de purificação de vetores virais está segmentado em empresas de biotecnologia, empresas farmacêuticas, organizações de investigação por contrato, organização de desenvolvimento e fabrico de contratos (CDMO) e institutos académicos/de investigação. Em 2021, prevê-se que o segmento dos institutos académicos/de investigação domine o mercado de purificação de vetores virais devido ao aumento das atividades de iniciativa de várias organizações de saúde e organismos governamentais para incentivar o esforço de investigação.
Análise a nível de país do mercado de purificação de vetores virais da Ásia-Pacífico
O mercado de purificação de vetores virais da Ásia-Pacífico é analisado e são fornecidas informações sobre o tamanho do mercado por país, produto e serviços, tipo, fluxo de trabalho, técnica de purificação, escala de operação, método de entrega, indicação de doença, aplicação e utilizador final como acima referido.
Os países abrangidos no relatório de mercado de purificação de vetores virais da Ásia-Pacífico são o Japão, China, Austrália, Índia, Coreia do Sul, Singapura, Indonésia, Tailândia, Malásia, Filipinas e resto da Ásia-Pacífico.
Espera-se que a Ásia-Pacífico cresça com o CAGR mais rápido no período de previsão, uma vez que nos países da Ásia-Pacífico, a procura de purificação de vetores virais está a aumentar muito rapidamente devido ao rápido aumento da população e ao aumento dos gastos com saúde. Espera-se que o Japão domine o mercado de purificação de vetores virais da Ásia-Pacífico, uma vez que o Japão é um dos países líderes da Ásia-Pacífico que utiliza produtos avançados de purificação de vetores virais para tratamentos.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, a presença e disponibilidade de marcas da Ásia-Pacífico e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto dos canais de vendas são considerados, ao mesmo tempo que fornece uma análise de previsão dos dados do país.
As iniciativas estratégicas dos fabricantes estão a criar novas oportunidades para os participantes do mercado de purificação de vetores virais
O mercado de purificação de vetores virais também fornece análises de mercado detalhadas para o crescimento de cada país. Além disso, fornece dados detalhados sobre o crescimento das vendas, parcerias, aquisições e acordos de distribuição de purificação de vetores virais entre os participantes do mercado de purificação de vetores virais da região Ásia-Pacífico. Os dados estão disponíveis para o período histórico de 2011 a 2019.
Análise do cenário competitivo e da quota de mercado da purificação de vetores virais
O panorama competitivo do mercado de purificação de vetores virais fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e amplitude do produto, domínio de aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco da empresa relacionado com o mercado de purificação de vetores virais da Ásia-Pacífico.
Os principais players abordados no relatório de mercado de purificação de vetores virais da Ásia-Pacífico são Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, Batavia Biosciences BV, Agilent Technologies, Inc., Addgene, Takara Bio Inc., Thermo Fisher Scientific Inc., uniQure NV, BioVision Inc., Cytiva (uma subsidiária da Danaher) e BIA Separations, entre outros players nacionais. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.
Muitos contratos e acordos são também iniciados pelas empresas de todo o mundo que também estão a acelerar o mercado de purificação de vetores virais.
Por exemplo,
- Em janeiro de 2021, a Thermo Fisher Scientific Inc. anunciou que concluiu a aquisição do negócio de fabrico de vetores virais da Novsep na Bélgica, o que ajudará a empresa a diversificar ainda mais o seu mercado.
A colaboração, as joint ventures e outras estratégias dos players do mercado estão a melhorar a impressão da empresa no mercado de purificação de vetores virais, o que também oferece o benefício para a organização melhorar o seu crescimento de vendas.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 RISING DEMAND FOR VIRAL VECTORS
4.1.2 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION
4.1.3 EMERGENCE OF COVID-19 AND DEMAND FOR VACCINE DEVELOPMENT
4.1.4 BENEFITS OF VIRAL VECTORS FOR GENE THERAPY
4.1.5 GROWING USAGE OF AAV VECTORS FOR DELIVERY OF SIRNA IN MAMMALIAN CELLS
4.2 RESTRAINTS
4.2.1 LACK OF SCALABILITY
4.2.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
4.3 OPPORTUNITIES
4.3.1 GROWING CANCER BURDEN WORLDWIDE
4.3.2 RISING NUMBER OF INFECTIOUS DISEASES
4.3.3 GROWING GERIATRIC POPULATION
4.3.4 RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE
4.4 CHALLENGES
4.4.1 BIOLOGICAL CHALLENGES
4.4.2 SHORTAGE OF SKILLED PERSONNEL
5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: REGULATIONS
1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES
1.1 OVERVIEW
1.2 PRODUCTS
1.2.1 RESIN
1.2.2 KIT
1.2.3 REAGENT
1.2.4 PREPACKED COLUMN
1.2.5 CASSETTE
1.2.6 CAPSULE
1.2.7 FILTER PLATE
1.3 SERVICES
2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE
2.1 OVERVIEW
2.2 CHROMATOGRAPHY
2.2.1 AFFINITY CHROMATOGRAPHY
2.2.2 ION-EXCHANGE CHROMATOGRAPHY
2.2.3 SIZE-EXCLUSION CHROMATOGRAPHY
2.2.4 HYDROPHILIC INTERACTION CHROMATOGRAPHY
2.3 DENSITY-GRADIENT ULTRACENTRIFUGATION
2.4 ULTRAFILTRATION
2.5 PRECIPITATION
2.6 TWO-PHASE EXTRACTION SYSTEMS
3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE
3.1 OVERVIEW
3.2 ADENO-ASSOCIATED VIRAL VECTORS
3.3 ADENOVIRAL VECTORS
3.3.1 MASTADENOVIRUS
3.3.2 AVIADENOVIRUS
3.3.3 SIADENOVIRUS
3.3.4 ATADENOVIRUS
3.3.5 ICHTADENOVIRUS
3.4 LENTIVIRUS
3.5 RETROVIRAL VECTORS
3.5.1 REPLICATION DEFECTIVE
3.5.2 REPLICATION-COMPETENT
3.6 VACCINE VIRUS
3.7 OTHER
4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW
4.1 OVERVIEW
4.2 UPSTREAM PROCESSING
4.3 DOWNSTREAM PROCESSING
5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION
5.1 OVERVIEW
5.2 PRECLINICAL / CLINICAL
5.3 COMMERCIAL
6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE
6.1 OVERVIEW
6.2 IN VIVO
6.3 EX VIVO
7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION
7.1 OVERVIEW
7.2 GENETIC DISORDERS
7.2.1 THALASSEMIA
7.2.2 CYSTIC FIBROSIS
7.2.3 TAY-SACHS DISEASE
7.2.4 SICKLE CELL ANEMIA
7.2.5 OTHERS
7.3 INFECTIOUS DISEASES
7.3.1 MEASLES VIRUS
7.3.2 VESICULAR STOMATITIS VIRUS
7.3.3 NOVEL ADENOVIRUSES
7.3.4 CYTOMEGALOVIRUS
7.3.5 OTHERS
7.4 VETERINARY DISEASE
7.5 CANCER
7.6 OTHER
8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 GENE THERAPY
8.2.1 RECOMBINANT PROTEIN EXPRESSION
8.2.2 FUNCTIONAL ASSAYS
8.2.3 PROTEIN CHARACTERIZATION
8.2.4 IN VITRO TRANSCRIPTION
8.2.5 OTHERS
8.3 CELL THERAPY
8.4 VACCINOLOGY
8.5 ANTISENSE & RNAI
9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER
9.1 OVERVIEW
9.2 ACADEMIC/ RESEARCH INSTITUTES
9.3 PHARMACEUTICAL COMPANIES
9.4 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
9.5 BIOTECHNOLOGY COMPANIES
9.6 CONTRACT RESEARCH ORGANIZATIONS
10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 JAPAN
10.1.2 SOUTH KOREA
10.1.3 AUSTRALIA
10.1.4 SINGAPORE
10.1.5 MALAYSIA
10.1.6 THAILAND
10.1.7 INDONESIA
10.1.8 PHILIPPINES
10.1.9 REST OF ASIA-PACIFIC
11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILE
12.1 THERMO FISHER SCIENTIFC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 CYTIVA (A SUBSIDIARY OF DANAHER)
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 AGILENT TECHNOLOGIES, INC.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.6 ADDGENE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 ALDEVRON
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 APPLIED BIOLOGICAL MATERIALS INC.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 BIA SEPARATIONS
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 BIO-RAD LABORATORIES, INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 BIOVISION INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENT
12.12 BATAVIA BIOSCIENCES B.V.
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENT
12.13 CREATIVE BIOGENE
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 CREATIVE BIOLABS
12.14.1 COMPANY SNAPSHOT
12.14.2 SERVICE PORTFOLIO
12.15 IDT BIOLOGIKA GMBH
12.15.1 COMPANY SNAPSHOT
12.15.2 PRODUCT PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 PROBIOGEN AG
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENTS
12.17 SIRION-BIOTECH GMBH
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 TAKARA BIO INC.
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 UNIQURE N.V.
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 RECENT DEVELOPMENT
12.2 WAISMAN BIOMANUFACTURING
12.20.1 COMPANY SNAPSHOT
12.20.2 PRODUCT PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
Lista de Tabela
LIST OF TABLES
TABLE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC SERVICES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC DENSITY-GRADIENT ULTRACENTRIFUGATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC ULTRAFILTRATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC PRECIPITATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC TWO-PHASE EXTRACTION SYSTEMS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ADENO-ASSOCIATED VIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC LENTIVIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC VACCINE VIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC UPSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC DOWNSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC PRECLINICAL / CLINICAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC COMMERCIAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC IN VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC EX VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC VETERINARY DISEASE IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANCER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC CELL THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC VACCINOLOGY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC ANTISENSE & RNAI IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC ACADEMIC/ RESEARCH INSTITUTES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC PHARMACEUTICAL COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 55 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 59 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 62 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 63 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 68 JAPAN PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 69 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 70 JAPAN CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 71 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 JAPAN RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 JAPAN ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 75 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 76 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 77 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 78 JAPAN GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 79 JAPAN INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 80 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 JAPAN GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 84 CHINA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 85 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 86 CHINA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 87 CHINA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 CHINA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 CHINA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 CHINA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 91 CHINA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 92 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 93 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 94 CHINA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 95 CHINA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 96 CHINA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 CHINA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 CHINA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 100 INDIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 101 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 INDIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 103 INDIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 INDIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 INDIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 INDIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 107 INDIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 108 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 109 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 110 INDIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 111 INDIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 112 INDIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 INDIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 INDIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 116 SOUTH KOREA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 117 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 118 SOUTH KOREA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 119 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 SOUTH KOREA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 SOUTH KOREA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 123 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 124 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 125 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 126 SOUTH KOREA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 127 SOUTH KOREA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 128 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 SOUTH KOREA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 132 AUSTRALIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 133 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 134 AUSTRALIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 135 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 AUSTRALIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 AUSTRALIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 139 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 140 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 141 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 142 AUSTRALIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 143 AUSTRALIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 144 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 145 AUSTRALIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 148 SINGAPORE PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 149 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 150 SINGAPORE CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 151 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 152 SINGAPORE RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 153 SINGAPORE ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 154 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 155 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 156 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 157 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 158 SINGAPORE GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 159 SINGAPORE INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 160 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 161 SINGAPORE GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 162 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 163 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 164 MALAYSIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 165 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 166 MALAYSIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 167 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 MALAYSIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 169 MALAYSIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 170 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 171 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 172 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 173 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 174 MALAYSIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 175 MALAYSIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 176 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 177 MALAYSIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 178 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 179 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 180 THAILAND PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 181 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 182 THAILAND CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 183 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 184 THAILAND RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 185 THAILAND ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 186 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 187 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 188 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 189 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 190 THAILAND GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 191 THAILAND INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 192 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 193 THAILAND GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 194 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 195 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 196 INDONESIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 197 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 198 INDONESIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 199 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 200 INDONESIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 201 INDONESIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 202 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 203 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 204 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 205 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 206 INDONESIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 207 INDONESIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 208 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 209 INDONESIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 210 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 211 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 212 PHILIPPINES PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 213 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 214 PHILIPPINES CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 215 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 216 PHILIPPINES RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 217 PHILIPPINES ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 218 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 219 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 220 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 221 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 222 PHILIPPINES GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 223 PHILIPPINES INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 224 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 225 PHILIPPINES GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 226 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 227 REST OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
Lista de Figura
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 12 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION IS DRIVING THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET
FIGURE 15 ESTIMATED NUMBER OF NEW CASES IN MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE IN 2018
FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2020
FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2021-2028 (USD MILLION)
FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, CAGR (2021-2028)
FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2020
FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2021-2028 (USD MILLION)
FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, CAGR (2021-2028)
FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, LIFELINE CURVE
FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2020
FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2021-2028 (USD MILLION)
FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 13 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2020
FIGURE 14 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2021-2028 (USD MILLION)
FIGURE 15 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, CAGR (2021-2028)
FIGURE 16 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, LIFELINE CURVE
FIGURE 17 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2020
FIGURE 18 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
FIGURE 19 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, CAGR (2021-2028)
FIGURE 20 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2020
FIGURE 22 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2021-2028 (USD MILLION)
FIGURE 23 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, CAGR (2021-2028)
FIGURE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2020
FIGURE 26 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2021-2028 (USD MILLION)
FIGURE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 28 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2020
FIGURE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 31 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2020
FIGURE 34 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 35 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 36 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SNAPSHOT (2020)
FIGURE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020)
FIGURE 39 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 40 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 41 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE (2021-2028)
FIGURE 42 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY SHARE 2020 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
